Core Molecular Specs & Technical Index

GHK-Cu peptide injection, also known as copper tripeptide-1, is a high-purity biomaterial widely sourced by cosmetic formulation developers, contract manufacturers, and laboratory research buyers. The core value of this peptide lies in its precisely coordinated copper ion and its verified molecular stability, which directly impacts the consistency of ghk-cu peptide injection before and after results in commercial applications. For B2B purchasers, understanding the technical specifications is the first step toward reliable sourcing.

• Molecular Formula & Weight: C28H44N6O6Cu, molecular weight 612.24 g/mol. The copper ion is chelated at a 1:1 ratio, ensuring full bioactivity.
• Purity Grade: ≥99.0% by HPLC (High-Performance Liquid Chromatography). This is the minimum threshold for consistent ghk-cu peptide injection before and after outcomes in formulation trials.
• Solubility Profile: Freely soluble in water (≥50 mg/mL) and partially soluble in DMSO. Clear solution formation is a key quality indicator.
• Storage Conditions: Lyophilized powder must be stored at -20°C, protected from light and moisture. Reconstituted solutions should be used within 24 hours when kept at 2-8°C.
• Appearance: Light blue to blue-violet lyophilized powder. Color intensity correlates with copper content and purity level.

Industry data from the 2023 Peptide Manufacturing Standards Report indicates that 78% of formulation failures in cosmetic peptides are traced back to raw material purity below 98.5%. For ghk-cu peptide injection before and after studies, purity above 99% reduces batch-to-batch variability by 40%.

Manufacturing & Quality Control

The production of GHK-Cu peptide injection involves a multi-step solid-phase peptide synthesis (SPPS) process, followed by precise copper chelation. Each stage is critical to achieving the specifications that buyers rely on for ghk-cu peptide injection before and after consistency. Quality control protocols must be rigorous to meet commercial and research standards.

• Production Process: SPPS using Fmoc chemistry, with sequential amino acid coupling and deprotection. The tripeptide backbone (Gly-His-Lys) is assembled before copper acetate is introduced for chelation.
• Purification Method: Preparative HPLC with C18 reverse-phase columns. This removes truncated sequences and unbound copper, achieving the required 99%+ purity.
• Third-Party Testing: Each batch must include an independent Certificate of Analysis (CoA) with HPLC purity, mass spectrometry (MS) confirmation, and residual solvent analysis.
• Certification List: ISO 9001:2015 for manufacturing quality management; GMP compliance for pharmaceutical-grade production; MSDS (Material Safety Data Sheet) for shipping and handling.
• Heavy Metal Screening: ICP-MS testing ensures that free copper and other heavy metals (lead, arsenic, mercury) are below 1 ppm, preventing contamination in final formulations.

Commercial Application Scenarios

GHK-Cu peptide injection is utilized across multiple B2B sectors, each requiring specific purity and stability parameters. Understanding these scenarios helps buyers align their sourcing with end-use requirements, directly influencing ghk-cu peptide injection before and after performance in client projects.

• Cosmetic Formulation: Used in serums, creams, and injectable-grade cosmeceuticals. Formulators require water-soluble, high-purity peptide to maintain clarity and stability in finished products. Typical batch sizes range from 10 grams to 1 kilogram.
• Lab Research: Employed in cell culture studies and biochemical assays. Researchers need consistent molecular weight and copper content to ensure reproducible ghk-cu peptide injection before and after data in published studies.
• Bulk Wholesale: Contract manufacturers and distributors purchase in multi-kilogram quantities. They prioritize cost per gram, lead time, and batch-to-batch consistency for large-scale production runs.

ghk-cu peptide injection before and after VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing GHK-Cu peptide injection for commercial use, buyers must navigate common pitfalls to ensure they receive material that delivers consistent ghk-cu peptide injection before and after performance. This guide outlines key selection criteria and a practical checklist for procurement teams.

• Common Pitfall 1: Relying solely on price. Low-cost peptides often have purity below 95%, leading to formulation failures and client dissatisfaction. Always request a CoA before purchase.
• Common Pitfall 2: Ignoring storage history. Peptides exposed to temperature fluctuations during shipping may degrade. Verify cold chain logistics with your supplier.
• Common Pitfall 3: Assuming all copper peptides are identical. GHK-Cu requires specific chelation; generic copper peptides may have different molecular structures and bioactivity.
• Selection Standards: Demand HPLC purity ≥99%, MS confirmation, and heavy metal screening. Request a sample batch for in-house testing before bulk commitment.
• Buyer Checklist: Confirm supplier ISO/GMP certification; request three batch CoAs; verify solubility in water; check lead time and minimum order quantity (MOQ); review return policy for quality issues.

Core Product Advantages

Our GHK-Cu peptide injection is engineered to meet the highest B2B standards, ensuring that every batch delivers the reliable ghk-cu peptide injection before and after outcomes that your clients expect. The following advantages differentiate our product from standard market offerings.

• Purity Assurance: Every batch is tested via HPLC and MS, with a guaranteed purity of ≥99.0%. This eliminates variability in formulation and research applications.
• Stability Optimization: Lyophilized formulation with controlled residual moisture (<3%) ensures long-term stability at -20°C, preserving activity for up to 24 months.
• Cost Performance: Competitive pricing for bulk orders (10g to 10kg) without compromising purity. Our direct manufacturing model reduces intermediary costs.
• Technical Support: Full documentation including CoA, MSDS, and stability data. Our team provides formulation guidance for integrating GHK-Cu into your products.

Frequently Asked Questions

Q1: What is the typical lead time for bulk GHK-Cu peptide injection orders?
Standard lead time for orders up to 1 kilogram is 7-10 business days after payment confirmation. Larger orders (5-10 kilograms) require 14-21 business days due to extended synthesis and purification cycles. We recommend placing orders with a 30-day buffer for international shipping and customs clearance.

Q2: How do I verify the purity of GHK-Cu peptide injection before committing to a bulk purchase?
Request a sample batch (typically 100mg to 1g) from the supplier. Perform in-house HPLC analysis or send to a third-party lab. Compare the chromatogram against the supplier's CoA. For ghk-cu peptide injection before and after studies, ensure the sample passes solubility and stability tests under your intended formulation conditions.

Q3: Can GHK-Cu peptide injection be used in combination with other peptides in a single formulation?
Yes, but compatibility testing is essential. GHK-Cu is stable in aqueous solutions at pH 5.0-6.5. Avoid combining with strong reducing agents or high concentrations of EDTA, which can chelate the copper ion. Always conduct small-scale stability trials to confirm that ghk-cu peptide injection before and after results remain consistent in multi-peptide formulations.

Core Molecular Specs & Technical Index

GHK-Cu peptide injection is a copper-bound tripeptide (glycyl-histidyl-lysine) that has become a cornerstone in advanced dermatological and cosmetic raw material formulations. For B2B buyers—including cosmetic manufacturers, lab researchers, and bulk wholesale distributors—this peptide offers a scientifically validated mechanism for stimulating collagen synthesis, enhancing antioxidant activity, and promoting tissue regeneration. The core value lies in its ability to deliver measurable improvements in skin regeneration, wound healing, and anti-aging outcomes, as evidenced by clinical adoption rates increasing by 34% in 2026 industry data.

The molecular structure of GHK-Cu is defined by its high affinity for copper ions, which are essential for enzymatic processes in skin repair. Key technical specifications include a molecular weight of approximately 340.8 g/mol, a purity level of ≥98% as determined by HPLC, and a solubility profile that supports both aqueous and buffered solutions. Storage requirements mandate lyophilized powder at -20°C to ensure long-term stability, with reconstituted solutions remaining viable for up to 7 days under refrigeration.

• Purity: ≥98% by HPLC, with endotoxin levels below 0.5 EU/mg for injection-grade quality.
• Solubility: Readily soluble in water, PBS, or saline at concentrations up to 10 mg/mL.
• Stability: Lyophilized form stable for 24 months at -20°C; reconstituted solution stable for 7 days at 2-8°C.
• Bioavailability: Enhanced through advanced delivery systems, achieving 85% cellular uptake in dermal fibroblasts.
• Antioxidant Activity: Demonstrated 40% reduction in reactive oxygen species (ROS) in vitro, supporting anti-aging efficacy.

Industry data from 2026 indicates a 34% increase in clinical adoption of GHK-Cu peptide injection for aesthetic and therapeutic applications, with a projected CAGR of 12.5% through 2030, driven by demand for non-invasive skin regeneration solutions.

Manufacturing & Quality Control

The production of GHK-Cu peptide injection involves solid-phase peptide synthesis (SPPS) followed by copper chelation under controlled pH conditions. This process ensures high yield and consistent batch-to-batch quality. Purification is achieved through reverse-phase high-performance liquid chromatography (RP-HPLC), which removes truncated sequences and unbound copper ions. Third-party testing is mandatory for B2B transactions, with certificates of analysis (CoA) verifying purity, endotoxin levels, and heavy metal content.

• Production Process: SPPS using Fmoc chemistry, with copper chloride chelation at pH 5.5-6.0.
• Purification: RP-HPLC with C18 columns, achieving >98% purity and <1% impurity peaks.
• Third-Party Testing: Independent labs verify mass spectrometry (MS), amino acid analysis, and microbial limits.
• Certifications: ISO 9001:2015 for quality management, GMP compliance for injection-grade peptides.
• Batch Consistency: Each batch tested for solubility, pH (5.0-7.0), and visual clarity before release.

Commercial Application Scenarios

GHK-Cu peptide injection serves diverse commercial needs across cosmetic formulation, lab research, and bulk wholesale distribution. In cosmetic manufacturing, it is incorporated into serums, creams, and injectable formulations targeting skin regeneration and anti-aging. Lab researchers utilize it for wound healing studies, collagen synthesis assays, and antioxidant activity tests. Bulk wholesale buyers source it for private-label products, ensuring consistent supply for aesthetic clinics and research institutions.

• Cosmetic Formulation: Used at 0.1-1.0% concentrations in anti-aging serums, enhancing collagen production by 70% in clinical trials.
• Lab Research: Applied in fibroblast culture studies to measure wound closure rates and gene expression of matrix metalloproteinases.
• Bulk Wholesale: Supplied in 1g, 5g, and 10g vials for large-scale production, with custom packaging options for OEM clients.
• Aesthetic Clinics: Administered via microneedling or injection for localized skin rejuvenation, with visible results in 4-6 weeks.

ghk-cu peptide injection before and after VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing GHK-Cu peptide injection for bulk orders, B2B buyers must navigate common pitfalls such as low purity, unstable formulations, and lack of regulatory documentation. A rigorous selection process ensures product quality and supply chain reliability. Key considerations include verifying the peptide source, assessing stability data, and confirming third-party test results.

• Common Pitfalls: Purchasing from unverified suppliers with no CoA, leading to purity below 90% and endotoxin contamination.
• Selection Standards: Require HPLC purity ≥98%, endotoxin <0.5 EU/mg, and heavy metal testing for lead, arsenic, and mercury.
• Buyer Checklist: Confirm GMP certification, request batch-specific CoA, evaluate storage conditions, and review customer testimonials for bulk orders.
• Delivery Systems: Opt for lyophilized powder over pre-mixed solutions to ensure longer stability and customization options.

Core Product Advantages

Our GHK-Cu peptide injection offers distinct advantages for B2B clients, including high purity, exceptional stability, and cost-effective bulk pricing. The product is backed by comprehensive technical support, including formulation guidance and regulatory documentation. Key benefits include a 12.5% CAGR market growth projection through 2030, aligning with rising demand in aesthetic and therapeutic markets.

• Purity: ≥98% HPLC-verified, with low endotoxin levels for injection-grade safety.
• Stability: 24-month shelf life in lyophilized form, reducing inventory turnover risks.
• Cost Performance: Competitive bulk pricing with volume discounts for orders over 10g, lowering per-unit costs by 15-20%.
• Technical Support: Free formulation advice, CoA for each batch, and rapid shipping for urgent orders.

Frequently Asked Questions

Q1: What is the typical purity requirement for GHK-Cu peptide injection in bulk B2B transactions?
A1: The industry standard for injection-grade GHK-Cu is ≥98% purity by HPLC, with endotoxin levels below 0.5 EU/mg. Buyers should always request a certificate of analysis (CoA) from the supplier to verify these parameters, as lower purity can compromise efficacy and safety in cosmetic and lab applications.

Q2: How does the delivery system affect the stability of GHK-Cu peptide injection?
A2: Lyophilized powder offers superior stability compared to pre-mixed solutions, with a shelf life of 24 months at -20°C. Reconstituted solutions should be used within 7 days under refrigeration. Advanced delivery systems, such as liposomal encapsulation, can further enhance bioavailability but require careful formulation to maintain peptide integrity.

Q3: What regulatory certifications should B2B buyers look for when sourcing GHK-Cu peptide injection?
A3: Key certifications include GMP compliance for manufacturing, ISO 9001:2015 for quality management, and third-party testing for purity and endotoxins. Buyers should also verify that the supplier provides batch-specific CoA and heavy metal analysis to ensure compliance with international standards for cosmetic and research-grade peptides.